Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Relation between strain dyssynchrony index determined by comprehensive assessment using speckle-tracking imaging and long-term outcome after cardiac resynchronization therapy for patients with heart failure.
Tatsumi K, Tanaka H, Matsumoto K, Kaneko A, Tsuji T, Ryo K, Fukuda Y, Norisada K, Onishi T, Yoshida A, Kawai H, Hirata K.
Am J Cardiol. 2012 Apr 15;109(8):1187-93. Epub 2012 Jan 19.
Related citations
Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
Topilsky Y, Hasin T, Oh JK, Borgeson DD, Boilson BA, Schirger JA, Clavell AL, Frantz RP, Tsutsui R, Liu M, Maltais S, Kushwaha SS, Pereira NL, Park SJ.
Circ Cardiovasc Imaging. 2011 Nov;4(6):648-61. Epub 2011 Sep 21.
Failure to unmask pseudonormal diastolic function by a valsalva maneuver: tricuspid insufficiency is a major factor.
Hu K, Liu D, Niemann M, Hatle L, Herrmann S, Voelker W, Ertl G, Bijnens B, Weidemann F.
Circ Cardiovasc Imaging. 2011 Nov;4(6):671-7. Epub 2011 Sep 19.
Informed consent in cardiac resynchronization therapy: what should be said?
Kramer DB, Brock DW, Tedrow UB.
Circ Cardiovasc Qual Outcomes. 2011 Sep;4(5):573-7. doi: 10.1161/CIRCOUTCOMES.111.961680. Review. No abstract available.
Quality-of-life implications of immediate surgery and watchful waiting in asymptomatic aortic stenosis: a decision-analytic model.
Gada H, Scuffham PA, Griffin B, Marwick TH.
Circ Cardiovasc Qual Outcomes. 2011 Sep;4(5):541-8. doi: 10.1161/CIRCOUTCOMES.111.961839. Epub 2011 Aug 30.
Efficacy and cost of an exercise program for functionally impaired older patients with heart failure: a randomized controlled trial.
Witham MD, Fulton RL, Greig CA, Johnston DW, Lang CC, van der Pol M, Boyers D, Struthers AD, McMurdo ME.
Circ Heart Fail. 2012 Mar 1;5(2):209-16. Epub 2012 Jan 23.
Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria.
Rosamond WD, Chang PP, Baggett C, Johnson A, Bertoni AG, Shahar E, Deswal A, Heiss G, Chambless LE.
Circ Heart Fail. 2012 Mar 1;5(2):152-9. Epub 2012 Jan 23.
Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial.
Rector TS, Carson PE, Anand IS, McMurray JJ, Zile MR, McKelvie RS, Komajda M, Kuskowski M, Massie BM; I-PRESERVE Trial Investigators.
Circ Heart Fail. 2012 Mar 1;5(2):217-25. Epub 2012 Jan 20.
Association of β-blocker exposure with outcomes in heart failure differs between African American and white patients.
Lanfear DE, Hrobowski TN, Peterson EL, Wells KE, Swadia TV, Spertus JA, Williams LK.
Circ Heart Fail. 2012 Mar 1;5(2):202-8. Epub 2012 Jan 19.
Weighing in on heart failure: the role of SERCA2a SUMOylation.
Schwartz RJ, Yeh ET.
Circ Res. 2012 Jan 20;110(2):198-9. No abstract available.
Distinct epigenomic features in end-stage failing human hearts.
Movassagh M, Choy MK, Knowles DA, Cordeddu L, Haider S, Down T, Siggens L, Vujic A, Simeoni I, Penkett C, Goddard M, Lio P, Bennett MR, Foo RS.
Circulation. 2011 Nov 29;124(22):2411-22. Epub 2011 Oct 24.
Predictors and importance of prolonged hospital stay after primary PCI for ST elevation myocardial infarction.
Schellings DA, Ottervanger JP, van 't Hof AW, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink And M, Suryapranata H; Zwolle Myocardial Infarction Study Group.
Coron Artery Dis. 2011 Nov;22(7):458-62.
Age-related effects of exercise training on diastolic function in heart failure with reduced ejection fraction: The Leipzig Exercise Intervention in Chronic Heart Failure and Aging (LEICA) Diastolic Dysfunction Study.
Sandri M, Kozarez I, Adams V, Mangner N, Höllriegel R, Erbs S, Linke A, Möbius-Winkler S, Thiery J, Kratzsch J, Teupser D, Mende M, Hambrecht R, Schuler G, Gielen S.
Eur Heart J. 2012 Jan 19. [Epub ahead of print]
AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.
Raake PW, Schlegel P, Ksienzyk J, Reinkober J, Barthelmes J, Schinkel S, Pleger S, Mier W, Haberkorn U, Koch WJ, Katus HA, Most P, Müller OJ.
It makes SENSE to take a safer road.
Cleland JG, Antony R.
Eur Heart J. 2011 Sep;32(18):2225-7. Epub 2011 May 6. No abstract available.
Cardiac resynchronization therapy in paediatric and congenital heart disease patients.
van der Hulst AE, Delgado V, Blom NA, van de Veire NR, Schalij MJ, Bax JJ, Roest AA, Holman ER.
Eur Heart J. 2011 Sep;32(18):2236-46. Epub 2011 Mar 30. Review.
Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome.
Messerli FH, Bangalore S, Makani H, Rimoldi SF, Allemann Y, White CJ, Textor S, Sleight P.
Eur Heart J. 2011 Sep;32(18):2231-5. Epub 2011 Mar 15. No abstract available.
Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry.
Waldum B, Westheim AS, Sandvik L, Flønæs B, Grundtvig M, Gullestad L, Hole T, Os I.
J Am Coll Cardiol. 2012 Jan 24;59(4):371-8.
Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
Thijssen J, Borleffs CJ, Delgado V, van Rees JB, Mooyaart EA, van Bommel RJ, van Erven L, Boersma E, Bax JJ, Schalij MJ.
J Am Coll Cardiol. 2011 Nov 22;58(22):2282-9.
Myocardial expression levels of micro-ribonucleic acids in patients with left ventricular assist devices signature of myocardial recovery, signature of reverse remodeling, or signature with no name?
Mann DL, Burkhoff D.
J Am Coll Cardiol. 2011 Nov 22;58(22):2279-81. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on